ACOG releases guidelines on diagnosis and management of polycystic ovary syndrome.
Schroeder
Barrett M
BM
D000312:Adrenal Hyperplasia, Congenital / Q000175:diagnosis*; D003276:Contraceptives, Oral / Q000627:therapeutic use*; D003924:Diabetes Mellitus, Type 2 / Q000150:complications; D005260:Female; D006801:Humans; D000451:Mineralocorticoid Receptor Antagonists / Q000627:therapeutic use; D011085:Polycystic Ovary Syndrome / Q000150:complications / Q000175:diagnosis* / Q000188:drug therapy; D012307:Risk Factors; D013148:Spironolactone / Q000627:therapeutic use
D003276:Contraceptives, Oral; D000451:Mineralocorticoid Receptor Antagonists; D013148:Spironolactone